H S

Dendreon's Provenge: Looking Past The Noise

eric.whitman:

2. Does p=0.01 indicates "maybe"? It is 4.5 MEDIAN SURVIVAL ADVANTAGE. Taxotere showed ONLY 11 weeks survival advantage. The second trial DID SHOW over 3 months of SURVIVAL ADVANTAGE but unfortunately it was underpowered, hence, it wasn't stat-sig. Please explain why P=0.01 is not stat-sig?

3. The question was CORRECTED so that it will be EXACTLY THE SAME as the efficacy questions that are being asked on every AdCom. Want to talk about Scher? Why don't you check his COI (Conflict Of Interests) here???

Shame on the FDA that overturned a drug with NO safety issue that a vast majority of the panel member found it to be efficacious. SHAME SHAME SHAME.

This is all about money, money and more money!